Dexmedetomidine regulate the malignancy of breast cancer cells by activating α2-adrenoceptor/ERK signaling pathway. - Concepedia

Concepedia

Publication | Closed Access

Dexmedetomidine regulate the malignancy of breast cancer cells by activating α2-adrenoceptor/ERK signaling pathway.

42

Citations

0

References

2016

Year

Ji Nn, Manlin Duan, Tong Jh, JG Xu, Zhang Ym, Shaohua Wang

Abstract

These data suggest that Dex could promote the proliferation, migration and invasion of breast cancer cells through the activation of α2B-adrenoceptor /ERK signaling.